Polar Asset Management Partners’s AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share AEON.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-27,348
| Closed | -$41.7K | – | 906 |
|
|
2024
Q1 | $41.7K | Hold |
27,348
| – | – | ﹤0.01% | 578 |
|
|
2023
Q4 | $2.39K | Hold |
27,348
| – | – | ﹤0.01% | 733 |
|
|
2023
Q3 | $4.37K | Hold |
27,348
| – | – | ﹤0.01% | 816 |
|
|
2023
Q2 | $2.46K | Hold |
27,348
| – | – | ﹤0.01% | 925 |
|
|
2023
Q1 | $1.5K | Hold |
27,348
| – | – | ﹤0.01% | 991 |
|
|
2022
Q4 | $1.25K | Hold |
27,348
| – | – | ﹤0.01% | 1157 |
|
|
2022
Q3 | $2K | Hold |
27,348
| – | – | ﹤0.01% | 1308 |
|
|
2022
Q2 | $4K | Hold |
27,348
| – | – | ﹤0.01% | 1286 |
|
|
2022
Q1 | $8K | Sell |
27,348
-9,000
| -25% | -$2.63K | ﹤0.01% | 1151 |
|
|
2021
Q4 | $19K | Sell |
36,348
-113,552
| -76% | -$59.4K | ﹤0.01% | 1219 |
|
|
2021
Q3 | $88K | Hold |
149,900
| – | – | ﹤0.01% | 1040 |
|
|
2021
Q2 | $150K | Buy |
+149,900
| New | +$150K | ﹤0.01% | 923 |
|